KTTA vs REGN: Which Stock is Better?
Side-by-side comparison of Pasithea Therapeutics Corp and Regeneron Pharmaceuticals Inc in 2026
KTTA
Pasithea Therapeutics Corp
—
REGN
Regeneron Pharmaceuticals Inc
$664.45
Key Metrics Comparison
| Metric | KTTA | REGN | Winner |
|---|---|---|---|
| Market Cap | $5.65M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze KTTA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KTTA or REGN a better investment?
Comparing KTTA and REGN: Pasithea Therapeutics Corp has a market cap of $5.65M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KTTA and REGN?
KTTA (Pasithea Therapeutics Corp) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KTTA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KTTA or REGN?
Both KTTA and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: KTTA or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: KTTA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $5.65M for KTTA.
Should I buy KTTA or REGN in 2026?
Both KTTA and REGN have investment merit. KTTA trades at $N/A while REGN trades at $664.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KTTA and REGN stock?
Key differences: Market Cap ($5.65M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy KTTA or REGN in 2026?
The choice between KTTA and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between KTTA and REGN?
KTTA (Pasithea Therapeutics Corp) has a market cap of $5.65M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.